NAYA Biosciences (NAYA) Competitors $0.31 +0.00 (+1.29%) As of 03:48 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsSEC FilingsTrends NAYA vs. POAI, MHUA, PAVM, ICU, STRR, AEMD, AMIX, NUWE, CHEK, and SINTShould you be buying NAYA Biosciences stock or one of its competitors? The main competitors of NAYA Biosciences include Predictive Oncology (POAI), Meihua International Medical Technologies (MHUA), PAVmed (PAVM), SeaStar Medical (ICU), Star Equity (STRR), Aethlon Medical (AEMD), Autonomix Medical (AMIX), Nuwellis (NUWE), Check-Cap (CHEK), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry. NAYA Biosciences vs. Predictive Oncology Meihua International Medical Technologies PAVmed SeaStar Medical Star Equity Aethlon Medical Autonomix Medical Nuwellis Check-Cap Sintx Technologies Predictive Oncology (NASDAQ:POAI) and NAYA Biosciences (NASDAQ:NAYA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, community ranking, profitability, earnings, risk, analyst recommendations and media sentiment. Which has better earnings & valuation, POAI or NAYA? NAYA Biosciences has higher revenue and earnings than Predictive Oncology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPredictive Oncology$1.48M4.94-$13.98M-$3.05-0.35NAYA Biosciences$6.23M0.35-$8.03MN/AN/A Does the media prefer POAI or NAYA? In the previous week, Predictive Oncology and Predictive Oncology both had 1 articles in the media. Predictive Oncology's average media sentiment score of 1.89 beat NAYA Biosciences' score of 1.87 indicating that Predictive Oncology is being referred to more favorably in the media. Company Overall Sentiment Predictive Oncology Very Positive NAYA Biosciences Very Positive Is POAI or NAYA more profitable? NAYA Biosciences has a net margin of -119.91% compared to Predictive Oncology's net margin of -1,012.32%. NAYA Biosciences' return on equity of 0.00% beat Predictive Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Predictive Oncology-1,012.32% -286.30% -122.11% NAYA Biosciences -119.91%N/A -41.72% Does the MarketBeat Community prefer POAI or NAYA? Predictive Oncology received 148 more outperform votes than NAYA Biosciences when rated by MarketBeat users. However, 100.00% of users gave NAYA Biosciences an outperform vote while only 64.22% of users gave Predictive Oncology an outperform vote. CompanyUnderperformOutperformPredictive OncologyOutperform Votes14964.22% Underperform Votes8335.78% NAYA BiosciencesOutperform Votes1100.00% Underperform VotesNo Votes Do analysts recommend POAI or NAYA? Predictive Oncology currently has a consensus price target of $3.00, suggesting a potential upside of 180.37%. NAYA Biosciences has a consensus price target of $2.00, suggesting a potential upside of 545.16%. Given NAYA Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe NAYA Biosciences is more favorable than Predictive Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00NAYA Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in POAI or NAYA? 9.0% of Predictive Oncology shares are owned by institutional investors. Comparatively, 12.0% of NAYA Biosciences shares are owned by institutional investors. 3.4% of Predictive Oncology shares are owned by company insiders. Comparatively, 1.8% of NAYA Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk & volatility, POAI or NAYA? Predictive Oncology has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, NAYA Biosciences has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500. SummaryNAYA Biosciences beats Predictive Oncology on 11 of the 15 factors compared between the two stocks. Remove Ads Get NAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NAYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAYA vs. The Competition Export to ExcelMetricNAYA BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.20M$4.31B$5.67B$8.01BDividend YieldN/A39.84%4.89%4.03%P/E RatioN/A27.6923.8318.90Price / Sales0.3550.09380.26118.45Price / CashN/A51.0838.0534.62Price / Book-0.156.036.834.18Net Income-$8.03M$67.09M$3.19B$246.59M7 Day Performance-2.18%0.30%-2.49%-3.40%1 Month Performance-13.89%-8.60%-7.50%-9.30%1 Year PerformanceN/A17.98%8.51%0.65% NAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAYANAYA BiosciencesN/A$0.31+1.3%$2.00+536.9%N/A$2.23M$6.23M0.0010Positive NewsGap UpPOAIPredictive Oncology1.955 of 5 stars$1.26-2.7%$3.00+139.0%-63.1%$8.49M$1.48M-0.4130MHUAMeihua International Medical Technologies1.0969 of 5 stars$0.31-2.1%N/A-55.0%$7.92M$94.25M0.00620Positive NewsGap DownPAVMPAVmed4.3253 of 5 stars$0.70+5.4%$19.00+2,626.0%-72.2%$7.72M$4.03M-0.1690Short Interest ↑ICUSeaStar Medical0.3167 of 5 stars$1.71+0.3%N/A-91.5%$7.59M$68,000.00-0.152Short Interest ↑Positive NewsSTRRStar Equity1.0761 of 5 stars$2.36+4.2%N/A-46.4%$7.58M$50.38M-0.92460AEMDAethlon Medical2.8938 of 5 stars$0.47-3.9%$7.00+1,392.5%-73.9%$6.78M$570,000.00-0.3010Analyst ForecastShort Interest ↓Positive NewsAMIXAutonomix Medical2.9794 of 5 stars$2.39-3.2%$28.00+1,071.1%-95.7%$5.91MN/A-0.191Short Interest ↓NUWENuwellis2.8502 of 5 stars$1.26+0.4%$17.00+1,254.6%-92.6%$5.49M$8.97M-0.0170Short Interest ↓News CoverageCHEKCheck-Cap0.4809 of 5 stars$0.81+2.3%N/A-61.0%$4.74MN/A-0.2780Analyst ForecastShort Interest ↑SINTSintx Technologies0.5896 of 5 stars$3.33flatN/A-87.2%$4.47M$1.64M-0.0740Short Interest ↑ Remove Ads Related Companies and Tools Related Companies POAI Alternatives MHUA Alternatives PAVM Alternatives ICU Alternatives STRR Alternatives AEMD Alternatives AMIX Alternatives NUWE Alternatives CHEK Alternatives SINT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NAYA) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredDOGE’s Next Move: Not what you thinkDonald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faste...Weiss Ratings | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
